Table 2.
CSF biomarker | sAPPα | sAPPβ | Aβ38 | Aβ40 | Aβ42 | |
---|---|---|---|---|---|---|
MC | sAPPα | 0.87 (<0.01) | 0.2 (0.4) | 0.09 (0.7) | -0.2 (0.4) | |
sAPPβ | 0.87 (<0.01) | 0.2 (0.3) | 0.1 (0.6) | -0.2 (0.5) | ||
Aβ38 | 0.2 (0.4) | 0.2 (0.3) | 0.93 (<0.0001) | 0.44 (0.06) | ||
Aβ40 | 0.09 (0.7) | 0.1 (0.6) | 0.93 (<0.0001) | 0.6 (0.01) | ||
Aβ42 | -0.2 (0.4) | -0.2 (0.5) | 0.44 (0.06) | 0.6 (0.01) | ||
APPswe | sAPPα | 0.2 (0.6) | 0.2 (0.7) | -0.03 (0.9) | ||
sAPPβ | n.a. | n.a. | n.a. | n.a. | n.a. | |
Aβ38 | 0.2 (0.6) | 0.9 (<0.001) | 0.7 (0.06) | |||
Aβ40 | 0.2 (0.7) | 0.9 (<0.001) | 0.8 (0.01) | |||
Aβ42 | -0.03 (0.9) | 0.7 (0.06) | 0.8 (0.01) | |||
PSEN1 | sAPPα | 0.66 (0.18) | 0.20 (0.7) | 0.20 (0.7) | 0.086 (0.9) | |
sAPPβ | 0.66 (0.18) | 0.60 (0.2) | 0.60 (0.2) | 0.54 (0.3) | ||
Aβ38 | 0.20 (0.7) | 0.60 (0.2) | 1 (<0.01) | 0.83 (0.06) | ||
Aβ40 | 0.20 (0.7) | 0.60 (0.2) | 1 (<0.01) | 0.83 (0.06) | ||
Aβ42 | 0.086 (0.9) | 0.54 (0.3) | 0.83 (0.06) | 0.83 (0.06) | ||
NC | sAPPα | 0.64 (<0.01) | 0.71 (<0.01) | 0.72 (<0.01) | 0.65 (<0.01) | |
sAPPβ | 0.64 (<0.01) | 0.28 (0.3) | 0.33 (0.2) | 0.29 (0.3) | ||
Aβ38 | 0.71 (<0.01) | 0.28 (0.3) | 0.98 (<0.0001) | 0.95 (<0.0001) | ||
Aβ40 | 0.72 (<0.01) | 0.33 (0.2) | 0.98 (<0.0001) | 0.98 (<0.0001) | ||
Aβ42 | 0.65 (<0.01) | 0.29 (0.3) | 0.95 (<0.0001) | 0.98 (<0.0001) |
Correlations between the products of APP processing in the mutation carrier group as a whole (MC), carriers of the APPswe and PSEN1 mutations separately and in the nonmutation carriers (NC)
Numbers represent Pearson/Spearman correlation coefficients (p values) (significant correlations in italics)
APP amyloid precursor protein, FAD familial Alzheimer’s disease, Aβ amyloid beta, MC mutation carriers, NC noncarriers